The history of the erectile dysfunction drug presents a intricate picture for those considering investment. While the initial introduction generated massive returns, the expiration of its exclusive rights opened the door to generic competitors, dramatically reducing sales. This presents a specific challenge for pharmaceutical companies banking on c

The history of Viagra, and its developer copyright, presents a complex case study for investors. At first a blockbuster drug, generating billions in sales , its patent expiration created a flood of lower-priced alternatives , significantly impacting its market share . While specific businesses may attempt to capitalize on related treatments , the p